EXELIXIS, INC. — Director's Dealing 2016

Aug 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2016-08-04

Reporting Person: Schwab Gisela (Pres Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-04	Common Stock	M	42338	$9.73	Acquired	174354	Direct
2016-08-04	Common Stock	S	42338	$11	Disposed	132016	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-04	Option (right to buy)	$9.73	M	42338	Disposed	2016-08-31	Common Stock (42338.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13806	Indirect

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2016.

F2: Represents 13,806 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 3, 2016.

F3: The option, representing the right to purchase a total of 175,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 1, 2010.